VIVUS (VVUS) Resumes Trading +17%
Share of VIVUS Inc. (Nasdaq: VVUS) resume trading up 17% after the FDA approved obesity drug Qsymia.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sarepta Therapeutics (SRPT) Pushes Higher Following Positive Article on Approval
- Paragon Shipping (PRGN) Sees Big Gains for Second Session
- TiVo (TIVO), Rovi Corp. (ROVI) Halted, News Pending
Create E-mail Alert Related CategoriesFDA, Momentum Movers, Trader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!